The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

NCT03185845 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

392

Enrollment

OTHER

Sponsor class

Conditions

COPD Exacerbation
PTE - Pulmonary Thromboembolism

Interventions

DRUG: Warfarin

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital